Clinical Trial Update: A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating the combination of Yondelis (trabectedin) and doxorubicin in patients with soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Yondelis (trabectedin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Soft Tissue Sarcoma, Sarcoma | Phase 1 | Status: COMPLETED